I
IPCA Laboratories
IPCALAB Share Price
Healthcare1,502.90
as on 05 Mar 2026 at 14:35
Market Cap
₹38,129 Cr
PE Ratio
39.80
ROCE
12.97%
IPCALAB Fundamentals
Company Valuation
Market Cap (₹ Cr.)
38,129
PE Ratio
39.80
PB Ratio
5.04
Dividend Yield
0.27%
ROE
9.39%
ROCE
12.97%
Book Value (₹)
292.74
Face Value (₹)
1.00
Share Holding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoters | 44.72% | 44.72% | 44.72% | 44.72% | 44.72% |
| Domestic Institutional Investors (DII) | 35.68% | 36.06% | 36.20% | 36.77% | 37.32% |
| Foreign Institutional Investors (FII) | 11.07% | 10.76% | 10.67% | 10.43% | 10.63% |
| Public Investors | 6.88% | 6.81% | 6.82% | 6.55% | 5.88% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
IPCALAB Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Midcap
BSE Scrip Code
524494
NSE Scrip Name
IPCALAB
ISIN
INE571A01038



